Impact of Belly Board on small bowel toxicity in carcinoma cervix

A prospective study to assess the impact of patient immobilisation using a Belly board device on small bowel toxicity among patients with carcinoma cervix receiving pelvic external beam radiotherapy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028235

Enrollment

Registered

2020-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Belly board device: Patient immobilization with and without belly board device. Acute toxicities are compared in both arms

Eligibility

Inclusion criteria

Inclusion criteria: 1)Biopsy proven cervix carcinoma patients. 2)ECOG performance status 0-2. 3)FIGO stage IB2 to IIIC1. 4)Patients who are willing to give consent.

Exclusion criteria

Exclusion criteria: 1)Patients who took radiation previously to pelvis & abdomen. 2)FIGO stages IA,IB1,IIIC2,IVA with VVF. 3)Patients with known distant metastasis. 4)Patients with ECOG status 3-4. 5)Pregnant and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Acute toxicitiesTimepoint: weekly during RT	—

Secondary

Measure	Time frame
Acute toxcitiesTimepoint: Monthly after RT	—

Countries

India

Contacts

Public ContactB V Subramanian

Sri Venkateswara institute of medical sciences

ravibalasubramanian@hotmail.com9849692950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026